Ignite Creation Date:
2024-05-06 @ 12:30 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03775486
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-30
First Post:
2018-11-27
Brief Title:
Study of DurvalumabOlaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer ORION
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-27
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-27
First Submit QC Date:
December 11 2018
Study First Post Date:
2018-12-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-12-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2021-12-08
Disp First Submit QC Date:
November 15 2022
Disp First Post Date:
2022-12-12
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-07-26
Last Update Post Date:
2024-04-30
Last Update Post Date Type:
ACTUAL